Chronic diseases impact the productivity and quality of life of many individuals and represent a large portion of health care spending. New approaches are needed to improve both the effectiveness and the efficiency of caring for chronically ill patients.
Improved health outcomes are possible when comprehensive and timely biological assessments are combined with tools that proactively engage patients, clinicians, and caregivers in the management of disease. ProterixBio is developing innovative products to transform the management of chronic diseases. Our initial focus is Chronic Obstructive Pulmonary Disease (COPD).
Billerica MA, September 12, 2017 - ProterixBio, Inc. today announced that results from a recent clinical study of subjects with chronic obstructive pulmonary disease (COPD) were presented this week at…
Read MoreProterixBio, Inc. will be attending Precision Medicine World Conference 2018 Silicon Valley, to be held January 22-24th at the Computer History Museum, Mountain View, CA. The Precision Medicine World…
Read More